ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Mallinckrodt and FTC Resolve Questcor Matter
americanpharmaceuticalreview
January 20, 2017Mallinckrodt announced that it has reached agreement with the U.S. Federal Trade Commission (FTC) to resolve, without admission of wrongdoing, the previously disclosed FTC investigation into the acquisition by Questcor Pharmaceuticals, Inc., of Synacthen?
Pharma Sources Insight January 2025
